Evidence map›Paper›PMID 16051829›Full record

ArticleJournal of virology2005

Characterization of neuraminidase-resistant mutants derived from rotavirus porcine strain OSU.

José Agustín López, Antonio José Maldonado, Marlene Gerder, José Abanero, Juan Murgich, Flor H Pujol, Ferdinando Liprandi, Juan Ernesto Ludert

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

José Agustín LópezCentro de Microbiología y Biología Celular, Instituto Venezolano de Investigaciones Científicas, Apartado postal 21827, Caracas 1020-A, Venezuela.
Antonio José Maldonado
Marlene Gerder
José Abanero
Juan Murgich
Flor H Pujol
Ferdinando Liprandi
Juan Ernesto Ludert
Instituto Venezolano de Investigaciones Científicas · VE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infection by some rotavirus strains requires the presence of sialic acid on the cell surface, its infectivity being reduced in cells treated with neuraminidase. A neuraminidase treatment-resistant mutant was isolated from the porcine rotavirus strain OSU. In reassortant strains, the neuraminidase-resistant phenotype segregated with the gene coding for VP4. The mutant retained its capacity to bind to sialic acid. The VP4 sequence of the mutant differed from that of the parental OSU strain in an Asp-to-Asn substitution at position 100. Neutralization escape mutants selected from an OSU neuraminidase-sensitive clone by monoclonal antibodies that failed to recognize the neuraminidase-resistant mutant strain carried the same mutation at position 100 and were also neuraminidase resistant. Neuraminidase sensitivity was restored when the mutation at position 100 was compensated for by a second mutation (Gln to Arg) at position 125. Molecular mechanics simulations suggest that the neuraminidase-resistant phenotype associated with mutation of OSU residue 100 from Asp to Asn reflects the conformational changes of the sialic acid cleft that accompany sialic acid binding.

Indexed as

AnimalsAntibodies, MonoclonalCapsid ProteinsCell LineN-Acetylneuraminic AcidNeuraminidaseProtein ConformationRNA-Binding ProteinsRotavirusSwineViral Nonstructural ProteinsAntibodies, MonoclonalCapsid ProteinsN-Acetylneuraminic AcidNeuraminidaseNS35 protein, rotavirusRNA-Binding ProteinsViral Nonstructural ProteinsVP4 protein, Rotavirus

Identifiers

PMID16051829
PMCPMC1182648
OpenAlexW2165127476

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.